LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.
NEW YORK (Reuters Health) - Threatening or screaming at teenagers may put them at higher risk for depression and disruptive behaviors such as rule-breaking, a new study suggests.
NEW YORK (Reuters Health) - Popular drugs that are used to control stomach acid may increase the risk of a serious vitamin deficiency, suggests a new study.
- An oral immunotherapy aimed at grass and pollen allergies has a benefit and safety profile that supports its approval, according to company documents posted on Monday by the U.S. Food and Drug Administration ahead of a meeting by outside experts to discuss the drug.
LONDON - Scientists have found that a mutation in a new strain of bird flu infecting people in China can render it resistant to a key first-line treatment drug without limiting its ability to spread in mammals.
NEW YORK (Reuters Health) - Young, low-income diabetics may not know they need annual eye exams, a new study suggests.
- AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, keeping the company well placed in a highly competitive race to deliver new treatments for the serious liver disease.
NEW YORK (Reuters Health) - Diverticulosis, a common condition that causes small pouches in the walls of the intestines, might not be as dangerous as doctors have thought.
- Merck & Co said it will begin two late-stage trials of its experimental Alzheimer's drug, one of the industry's best hopes for slowing the memory-robbing disease, after an independent monitoring board reviewed its safety and recommended that more patients be recruited for studies.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage